Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma

Background/Aim: Nivolumab, an anti-PD-1 inhibitor, has demonstrated efficacy in patients with several types of recurrent and metastatic (R/M) squamous cell carcinoma of the head and neck. We evaluated patients with R/M-NPC receiving nivolumab. Patients and Methods: Twelve patients with R/M-NPC were...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Main Authors: SATO, HIROKI, FUSHIMI, CHIHIRO, OKADA, TAKURO, MATSUKI, TAKASHI, KONDO, TAKAHITO, OMURA, GO, MIURA, KOUKI, YAMASHITA, TAKU, OKAMOTO, ISAKU, TSUKAHARA, KIYOAKI
Formato: Artigo
Idioma:Inglês
Publicado: International Institute of Anticancer Research 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652473/
https://ncbi.nlm.nih.gov/pubmed/32871839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12127
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares